Seroatlas · Human Serome Atlas

RRM2

Ribonucleoside-diphosphate reductase subunit M2

Also known as: C2orf48, FLJ25102, RIR2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P31350
Gene
RRM2
Ensembl
ENSG00000171848
Chromosome
2
Canonical length
389 aa
Protein class
Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

This gene encodes one of two non-identical subunits for ribonucleotide reductase. This reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides. Synthesis of the encoded protein (M2) is regulated in a cell-cycle dependent fashion. Transcription from this gene can initiate from alternative promoters, which results in two isoforms that differ in the lengths of their N-termini. Related pseudogenes have been identified on chromosomes 1 and X. [provided by RefSeq, Sep 2009]

Canonical amino-acid sequenceUniProt

389 residues, UniProt reviewed canonical sequence.

>P31350|RRM2
     1  MLSLRVPLAP ITDPQQLQLS PLKGLSLVDK ENTPPALSGT RVLASKTARR IFQEPTEPKT
    61  KAAAPGVEDE PLLRENPRRF VIFPIEYHDI WQMYKKAEAS FWTAEEVDLS KDIQHWESLK
   121  PEERYFISHV LAFFAASDGI VNENLVERFS QEVQITEARC FYGFQIAMEN IHSEMYSLLI
   181  DTYIKDPKER EFLFNAIETM PCVKKKADWA LRWIGDKEAT YGERVVAFAA VEGIFFSGSF
   241  ASIFWLKKRG LMPGLTFSNE LISRDEGLHC DFACLMFKHL VHKPSEERVR EIIINAVRIE
   301  QEFLTEALPV KLIGMNCTLM KQYIEFVADR LMLELGFSKV FRVENPFDFM ENISLEGKTN
   361  FFEKRVGEYQ RMGVMSSPTE NSFTLDADF

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RRM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
54 nTPM

Expression across tissuesHPA

Tissue

  • thymus: 54 nTPM
  • bone marrow: 42 nTPM
  • tonsil: 35 nTPM
  • lymph node: 33 nTPM
  • rectum: 19 nTPM
  • colon: 13 nTPM

Single-cell type

  • monocyte progenitors: 409 nCPM
  • extravillous trophoblasts: 336 nCPM
  • neutrophil progenitors: 279 nCPM
  • erythrocyte progenitors: 193 nCPM
  • esophageal basal cells: 170 nCPM
  • enteric transient amplifying cells: 146 nCPM

Immune cell

  • gdT-cell: 1.2 nTPM
  • memory CD8 T-cell: 0.8 nTPM
  • NK-cell: 0.8 nTPM
  • naive CD8 T-cell: 0.4 nTPM
  • neutrophil: 0.4 nTPM
  • basophil: 0.3 nTPM

Brain region

  • choroid plexus: 4.8 nTPM
  • thalamus: 2.7 nTPM
  • cerebellum: 1.8 nTPM
  • cerebral cortex: 1.8 nTPM
  • medulla oblongata: 1.7 nTPM
  • midbrain: 1.7 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.42
gnomAD pLI
0.75
gnomAD missense Z
2.34
DepMap mean gene effect
-2.34
DepMap dependency class
pan

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of RRM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RRM2 as an antibody target. Whether an autoantibody or antibody against RRM2 could matter depends on whether native RRM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RRM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RRM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RRM2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...